TXA Central
TXA Central is a resource for health professionals caring for patients with acute severe bleeding
Author: Catherine Gilliam
Tranexamic Acid Treatment in Trauma Patients with Varying Degrees of Injury
Researchers from the UK and Switzerland have conducted a meta-analysis of the effect of TXA treatment on over 32,000 trauma patients. Their aim was to discover whether survival differs between severely and non-severely injured patients.
Details
Alternative routes to intravenous tranexamic acid for postpartum haemorrhage
Recent research highlights ongoing trials assessing alternatives to intravenous TXA administration. Read the full article here
Details
Injured Women Half as Likely as Men to Receive Tranexamic Acid
New research has found that female trauma patients are half as likely as men to receive tranexamic acid – even though the treatment is equally effective regardless of sex. This highlights the urgent need to improve equity in trauma care. Read the full article here.
Details
Cost-effectiveness of TXA for older adults experiencing mild traumatic brain injury
Mild traumatic brain injury in older adults is a huge problem in the UK. Finding out if tranexamic acid improves outcomes is well worth the cost according to recent economic modelling. The CRASH-4 trial will answer this important question. Read the full article here.
Details
‘HER LIFE MATTERS’ DOCUMENTARY IS LIVE
This documentary ‘Her Life Matters’ asks why each year, world-wide tens of thousands of mothers bleed to death needlessly – lives that could be saved by a single injection of an inexpensive generic drug called tranexamic acid. Tranexamic acid was invented sixty years ago to stop mothers from bleeding to death after childbirth. The Woman trial showed that timely treatment
Details